Novel B cell epitopes from clinical isolates of M. tuberculosis elicit robust humoral immunity in pulmonary tuberculosis patients: A prospective immunogenic strategy for TB management
Novel B cell epitopes from clinical isolates of M. tuberculosis elicit robust humoral immunity in pulmonary tuberculosis patients: A prospective immunogenic strategy for TB management. // Indian Journal of Tuberculosis. – URL: https://www.sciencedirect.com/science/article/pii/S0019570726002234?dgcid=rss_sd_all
Novel B cell epitopes from clinical isolates of M. tuberculosis elicit robust humoral immunity in pulmonary tuberculosis patients: A prospective immunogenic strategy for TB management. Indian Journal of Tuberculosis. https://www.sciencedirect.com/science/article/pii/S0019570726002234?dgcid=rss_sd_all
“Novel B cell epitopes from clinical isolates of M. tuberculosis elicit robust humoral immunity in pulmonary tuberculosis patients: A prospective immunogenic strategy for TB management.” Indian Journal of Tuberculosis.
@article{article49041,
title = {Novel B cell epitopes from clinical isolates of M. tuberculosis elicit robust humoral immunity in pulmonary tuberculosis patients: A prospective immunogenic strategy for TB management},
journal = {Indian Journal of Tuberculosis},
url = {https://www.sciencedirect.com/science/article/pii/S0019570726002234?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...